EASL-AASLD joint meeting on alcoholic liver disease and alcoholic hepatitis London, England, UK 30 September - 1 October, 2017

Description:
During the EASL-AASLD joint meeting on "Definition, therapeutic advances and clinical endpoints in alcoholic liver disease and alcoholic hepatitis" topics on public health, diagnostic definitions, therapeutic advances and clinical endpoints in alcohol related liver disease and alcoholic hepatitis will be discussed.

Alcohol related liver disease (ALD) is the most prevalent cause of advanced liver disease and liver related mortality in Western countries.
Research in ALD spans a wide spectrum from public health to basic science and despite being the ‘Cinderella’ disease area in hepatology, there have been a number of advances in recent years. We would like to take this opportunity to review with you the emerging data from clinical, translational and basic science studies in ALD. Furthermore, as pharmaceutical company interest in ALD begins to evolve we would encourage you to participate in discussions around the endpoints in clinical trials.

This conference will be a unique occasion to interact with experts and top-researchers, to get new ideas but also to contribute in the field of therapeutic development in ALD and alcoholic hepatitis.

Price: EUR 50 - EUR 850